Ignite Creation Date:
2024-05-05 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006340
Status:
COMPLETED
Last Update Posted:
2013-07-26
First Post:
2000-10-04
Brief Title:
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Sponsor:
Boston Medical Center
Organization:
Boston Medical Center
Organization Data
Organization:
Boston Medical Center
Class:
OTHER
Study ID:
CDR0000064947
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boston Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None